newsfilter
← Latest News
Business Wire·

Join OS Therapies' Exclusive Live Investor Webinar and Q&A Session on October 30

OS Therapies (NYSE:OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, is pleased to invite investors to a webinar on October 30, 2024, at